PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.75% to £21.30 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.73% to ...

Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £21.84, which the company achieved on ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Hikma Pharmaceuticals (LON:HIK – Free Report) had its price objective lifted by Berenberg Bank from GBX 2,400 ($29.74) to GBX 2,560 ($31.73) in a research note published on Wednesday morning, ...

The introduction of the Shield™ test for colorectal cancer screening marks a transformative step in advancing precision and ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K. dividend aristocrats. In recent years, investors have turned away from UK ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...